CYH Community Health Systems, Inc. Common Stock
NYSE · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Tem 23, 2026CYH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
CYH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 22 Nisan 2016 | 121-for-100 | İleri |
Community Health Systems, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.
On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.
Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.
History
Founding and early years (1985–2014)
E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.
The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.
In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.
In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.
In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.
In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.
In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.
On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.
It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.
Recent developments (2015–present)
On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.
In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.
After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.
On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.
In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.
In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.
In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.
On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.
On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.
On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.
In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.
On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.
On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.
In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.
In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.
Predatory liens practices
Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | CYH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | 1.55Y ort. ≈3.4 | ≈3.4 | 15.5 | Düşük değerli | |
| F/S (TTM) | 0.05Y ort. ≈0.1 | ≈0.1 | 1.2 | Düşük değerli | |
| F/D (MRQ) | -0.35Y ort. ≈-0.5 | ≈-0.5 | · | · | |
| EV / EBITDA | 7.15Y ort. ≈13.1 | ≈13.1 | 10.6 | Düşük değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -2.15Y ort. ≈-0.8 | ≈-0.8 | · | · | |
| Fiyat / Nakit Akışı (TTM) | 3.05Y ort. ≈-1.6 | ≈-1.6 | 6.5 | Düşük değerli | |
| EV / Revenue (EV / Gelir) | 0.85Y ort. ≈1.0 | ≈1.0 | · | · | |
| EV / FCF | 50.55Y ort. ≈-4.9 | ≈-4.9 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | CYH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | 11.4%5Y ort. ≈8.4% | ≈8.4% | 13.8% | Aynı seviyede | |
| EBITDA Margin (FAVÖK Marjı) | 11.9%5Y ort. ≈8.4% | ≈8.4% | 10.2% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | 3.9%5Y ort. ≈2.4% | ≈2.4% | 6.4% | Aynı seviyede | |
| Net Kâr Marjı (TTM) | 2.1%5Y ort. ≈0.24% | ≈0.24% | 4.3% | Zayıf | |
| ROA (TTM) | 2.0%5Y ort. ≈0.20% | ≈0.20% | 3.7% | Aynı seviyede | |
| ROE (TTM) | -16.7%5Y ort. ≈-1.7% | ≈-1.7% | 8.2% | Zayıf | |
| ROIC | 15.5%5Y ort. ≈7.4% | ≈7.4% | 10.2% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | CYH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Borç / Öz Sermaye (MRQ) | -6.95Y ort. ≈-7.8 | ≈-7.8 | 0.3 | Düşük borç | |
| Cari Oran (MRQ) | 1.55Y ort. ≈1.5 | ≈1.5 | 1.5 | Aynı seviyede | |
| Quick Ratio (Cari Oran) | 1.15Y ort. ≈1.0 | ≈1.0 | 1.0 | Aynı seviyede | |
| Uzun Vadeli Borç / Özkaynak (MRQ) | -6.95Y ort. ≈-7.8 | ≈-7.8 | 0.3 | Düşük borç |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | CYH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -1.2%5Y ort. ≈1.2% | ≈1.2% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 0.74%5Y ort. ≈1.1% | ≈1.1% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 1.1% | · | · | · | |
| EPS CAGR 3Y (EPS Bileşik Yıllık Büyüme Oranı 3Y) | 120.8% | · | · | · | |
| EPS CAGR 5Y (EPS Bileşik Yıllık Büyüme Oranı 5Y) | -3.0% | · | · | · | |
| Net Income CAGR 3Y (Net Gelir Bileşik Yıllık Büyüme Oranı 3Y) | 122.8% | · | · | · | |
| Net Income CAGR 5Y (Net Gelir Bileşik Yıllık Büyüme Oranı 5Y) | -0.08% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | CYH | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.95Y ort. ≈0.9 | ≈0.9 | 0.9 | Aynı seviyede | |
| Receivables Turnover (Alacak Devir Hızı) | 5.75Y ort. ≈5.9 | ≈5.9 | 8.9 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$283.8K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Ara 13, 2012 | $0,21 | USD | ≈0.84% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Tem 21, 2026 | $-0.19 | $-0.06 | -201.1% |
| 31 Mart 2026 | $-0.48 | $-0.10 | -387.3% | |
| 31 Aralık 2025 | $-0.01 | $-0.10 | 90.5% | |
| 30 Eylül 2025 | $1.27 | $-0.25 | 610.5% | |
| 30 Haziran 2025 | $-0.05 | $-0.11 | 52.6% | |
| 31 Mart 2025 | $-0.03 | $-0.08 | 62.6% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Cost of Revenue | $1.86B | $1.95B | $1.99B | $1.98B | $2.04B | $1.96B | $2.15B | $2.35B | $2.67B | $3.01B | |
| Operating Expenses | $11.00B | $12.09B | $11.53B | $11.39B | $10.97B | $10.66B | $12.56B | $13.95B | $17.23B | $19.30B | |
| Operating Income | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $650M | $208M | $-1.88B | $-860M | |
| Interest Income | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $7M | $11M | $14M | |
| Pretax Income | $724M | $-283M | $207M | $349M | $499M | $422M | $-430M | $-715M | $-2.83B | $-1.72B | |
| Income Tax | $48M | $79M | $191M | $170M | $131M | $-185M | $160M | $-11M | $-449M | $-104M | |
| Net Income | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| EPS (Basic) | $3.81 | $-3.90 | $-1.02 | $0.35 | $1.82 | $4.43 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| EPS (Diluted) | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 | $4.39 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| Shares (Basic) | 133,564,227 | 132,101,768 | 130,445,677 | 128,808,387 | 126,754,852 | 115,491,022 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| Shares (Diluted) | 135,012,240 | 132,101,768 | 130,445,677 | 130,060,319 | 130,597,410 | 116,544,561 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| EBITDA | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $1.26B | $908M | $-1.02B | $240M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $260M | $37M | $38M | $118M | $507M | $1.68B | $216M | $196M | $563M | $238M | |
| Receivables | $2.08B | $2.29B | $2.23B | $2.04B | $2.06B | $1.93B | $2.26B | $2.35B | $2.38B | $3.18B | |
| Other Current Assets | $381M | $358M | $275M | $235M | $269M | $338M | $358M | $400M | $462M | $568M | |
| Current Assets | $3.23B | $3.30B | $3.21B | $3.08B | $3.48B | $4.51B | $3.43B | $3.55B | $4.07B | $4.67B | |
| PP&E (Net) | $4.50B | $4.78B | $5.21B | $5.37B | $5.55B | $5.32B | $5.61B | $6.14B | $7.05B | $8.15B | |
| PP&E (Gross) | $8.91B | $9.16B | $9.51B | $9.64B | $9.76B | $9.35B | $9.65B | $10.30B | $11.50B | $12.42B | |
| Accum. Depreciation | $4.41B | $4.38B | $4.30B | $4.27B | $4.20B | $4.03B | $4.04B | $4.16B | $4.45B | $4.27B | |
| Goodwill | $3.32B | $3.79B | $3.96B | $4.17B | $4.22B | $4.22B | $4.33B | $4.56B | $4.72B | $6.52B | |
| Intangibles | $7M | $15M | $20M | $2M | · | · | · | · | $10M | $14M | |
| Other Non-current Assets | $2.10B | $2.17B | $2.05B | $2.01B | $1.91B | $1.90B | $2.21B | $1.54B | $1.54B | $2.59B | |
| Total Assets | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Accounts Payable | $842M | $913M | $912M | $773M | $830M | $783M | $811M | $887M | $967M | $995M | |
| Accrued Liabilities | · | · | · | · | · | · | $1.13B | $1.09B | $1.13B | $1.23B | |
| Current Liabilities | $2.21B | $2.35B | $2.14B | $2.19B | $2.36B | $2.81B | $2.28B | $2.39B | $2.36B | $2.89B | |
| Capital Leases | $537M | $535M | $563M | $605M | $535M | $524M | $487M | $84M | $287M | $302M | |
| Deferred Tax | $25M | $231M | $369M | $354M | $192M | $29M | $200M | $26M | $19M | $411M | |
| Other Non-current Liabilities | $891M | $828M | $739M | $644M | $827M | $1.60B | $894M | $1.01B | $1.36B | $1.57B | |
| Total Liabilities | $14.04B | $15.37B | $15.28B | $15.40B | $16.03B | $17.06B | $17.25B | $16.82B | $17.61B | $19.66B | |
| Long-term Debt | $10.40B | $11.45B | $11.49B | $11.63B | $12.14B | $12.22B | $13.40B | $13.60B | $13.91B | $15.24B | |
| Total Debt | $10.38B | $11.43B | $11.47B | $11.61B | $12.11B | $12.09B | $13.38B | · | · | · | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Retained Earnings | $-3.57B | $-4.08B | $-3.56B | $-3.43B | $-3.48B | $-3.71B | $-4.22B | $-3.54B | $-2.76B | $-299M | |
| AOCI | $-9M | $-10M | $-14M | $-21M | $-14M | $-13M | $-9M | $-10M | $-21M | $-62M | |
| Stockholders' Equity | $-1.39B | $-1.91B | $-1.39B | $-1.37B | $-1.37B | $-1.62B | $-2.22B | $-1.53B | $-767M | $1.61B | |
| Liabilities + Equity | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Shares Outstanding | 138,626,917 | 138,919,641 | 136,774,911 | 134,703,717 | 132,146,282 | 129,612,117 | 117,822,631 | 116,248,376 | 114,651,004 | 113,876,580 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $426M | $486M | $505M | $534M | $540M | $558M | $608M | $700M | $861M | $1.10B | |
| Stock-based Comp | $11M | $17M | $22M | $20M | $25M | $13M | $10M | $13M | $24M | $46M | |
| Deferred Tax | $-243M | $-116M | $35M | $165M | $171M | $-187M | $203M | $-3M | $-454M | $-116M | |
| Restructuring | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | $239M | $352M | $2.80B | $1.83B | |
| Operating Cash Flow | $543M | $480M | $210M | $300M | $-131M | $2.18B | $385M | $274M | $773M | $1.14B | |
| CapEx | $335M | $360M | $467M | $415M | $469M | $440M | $438M | $527M | $564M | $744M | |
| Investing Cash Flow | $847M | $-275M | $-26M | $-259M | $-524M | $177M | $-2M | $-245M | $1.07B | $630M | |
| Net Debt Issued | $-6.52B | $-5.06B | $-4.32B | $-2.36B | $-4.43B | $-5.49B | $-3.56B | $-2.03B | $-5.39B | $-6.71B | |
| Financing Cash Flow | $-1.17B | $-206M | $-264M | $-430M | $-514M | $-895M | $-363M | $-396M | $-1.52B | $-1.71B | |
| Net Change in Cash | $223M | $-1M | $-80M | $-389M | $-1.17B | $1.46B | $20M | $-367M | $325M | $54M | |
| Taxes Paid | $249M | $171M | $91M | $-6M | $-4M | $-2M | $3M | $19M | $-4M | $16M | |
| Free Cash Flow | $208M | $120M | $-257M | $-115M | $-600M | $1.74B | $-53M | $-253M | $209M | $393M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 4.9% | 1.5% | · | · | |
| Net Margin | 4.1% | -4.1% | -1.1% | 0.38% | 1.9% | 4.3% | -5.1% | -5.6% | · | · | |
| Pretax Margin | 5.8% | -2.2% | 1.7% | 2.9% | 4.0% | 3.6% | -3.3% | -5.1% | · | · | |
| EBITDA Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 9.5% | 6.4% | · | · | |
| ROA | 3.7% | -3.6% | -0.91% | 0.31% | 1.5% | 3.2% | -4.3% | -4.7% | -12.5% | -7.1% | |
| ROE | -30.8% | 31.2% | 9.6% | -3.4% | -15.3% | -26.6% | 36.0% | 68.5% | -580.0% | -61.1% | |
| ROIC | 15.5% | 7.3% | 0.73% | 4.1% | 9.6% | 15.5% | 8.0% | -13.3% | 206.0% | -50.0% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 | 1.6 | 1.5 | 1.5 | 1.7 | 1.6 | |
| Quick Ratio | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 | 1.1 | 1.1 | 1.3 | 1.2 | |
| Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · | |
| LT Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | |
| Receivables Turnover | 5.7 | 5.6 | 5.8 | 6.0 | 6.2 | 5.6 | 5.7 | 6.0 | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-10.06 | $-13.78 | $-10.18 | $-10.15 | $-10.38 | $-12.54 | $-18.82 | $-13.20 | $-6.69 | $14.18 | |
| Revenue / Share | $92.47 | $95.64 | $95.75 | $93.89 | $94.70 | $101.15 | $116.14 | $125.57 | · | · | |
| Cash Flow / Share | $4.02 | $3.63 | $1.61 | $2.31 | $-1.00 | $18.69 | $3.38 | $2.43 | $6.92 | $10.27 | |
| Cash / Share | $1.88 | $0.27 | $0.28 | $0.88 | $3.84 | $12.93 | $1.83 | $1.69 | $4.91 | $2.09 | |
| EPS (TTM) | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 | $4.39 | $-5.93 | $-6.99 | $-22.00 | $-15.54 |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.2% | 1.1% | 2.3% | -1.3% | 4.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.74% | 0.71% | 1.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.1% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -80.1% | -59.9% | · | · | · | · | · | |
| EPS CAGR 3Y | 120.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -80.0% | -55.0% | · | · | · | · | · | |
| Net Income CAGR 3Y | 122.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.08% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Net Income TTM | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| Market Cap | $433M | $415M | $428M | $582M | $1.76B | $963M | $342M | $328M | $488M | $637M | |
| Enterprise Value | $10.55B | $11.81B | $11.86B | $12.08B | $13.36B | $11.38B | $13.51B | · | · | · | |
| P/E | 0.8 | -0.8 | -3.1 | 12.3 | 7.6 | 1.7 | -0.5 | -0.4 | -0.2 | -0.4 | |
| P/S | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| P/B | -0.3 | -0.2 | -0.3 | -0.4 | -1.3 | -0.6 | -0.2 | -0.2 | -0.6 | 0.4 | |
| P / Cash Flow | 0.8 | 0.9 | 2.0 | 1.9 | -13.4 | 0.4 | 0.9 | 1.2 | 0.6 | 0.6 | |
| P / FCF | 2.1 | 3.5 | -1.7 | -5.1 | -2.9 | 0.6 | -6.4 | -1.3 | 2.3 | 1.6 | |
| EV / EBITDA | 7.1 | 21.8 | 12.4 | 14.7 | 9.5 | 10.1 | 10.7 | · | · | · | |
| EV / FCF | 50.7 | 98.4 | -46.1 | -105.0 | -22.3 | 6.5 | -254.9 | · | · | · | |
| EV / Revenue | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 1.0 | 1.0 | · | · | · | |
| Earnings Yield | 120.8% | -130.4% | -32.6% | 8.1% | 13.2% | 59.1% | -204.5% | -247.9% | -516.4% | -278.0% |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.83B | $2.96B | $3.11B | $3.09B | $3.13B | $3.16B | $3.26B | $3.09B | $3.14B | $3.14B | $3.18B | $3.09B | $3.12B | $3.11B | $3.14B | $3.02B | |
| Cost of Revenue | $401M | $441M | $446M | $460M | $469M | $489M | $507M | $469M | $483M | $487M | $493M | $489M | $504M | $507M | $497M | $492M | |
| Operating Expenses | $2.44B | $2.68B | $2.66B | $2.84B | $2.62B | $2.88B | $2.99B | $3.29B | $2.90B | $2.91B | $2.85B | $2.91B | $2.87B | $2.90B | $2.91B | $2.82B | |
| Operating Income | $389M | $281M | $449M | $243M | $512M | $284M | $278M | $-205M | $238M | $231M | $328M | $173M | $246M | $210M | $228M | $204M | |
| Interest Income | $1M | $1M | $0 | $1M | $1M | · | $1M | $1M | · | · | · | · | · | · | · | · | |
| Pretax Income | $180M | $64M | $221M | $-2M | $438M | $67M | $64M | $-419M | $50M | $22M | $194M | $-33M | $40M | $6M | $324M | $70M | |
| Income Tax | $76M | $89M | $61M | $-173M | $118M | $42M | $91M | $-64M | $24M | $28M | $108M | $19M | $38M | $26M | $-123M | $70M | |
| Net Income | $70M | $-58M | $110M | $130M | $282M | $-13M | $-71M | $-391M | $-13M | $-41M | $47M | $-91M | $-38M | $-51M | $415M | $-42M | |
| EPS (Basic) | $0.51 | $-0.43 | $0.83 | $0.97 | $2.11 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| EPS (Diluted) | $0.51 | $-0.43 | $0.82 | $0.96 | $2.09 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| Shares (Basic) | 135,494,789 | 134,417,158 | · | 133,787,535 | 133,763,733 | 132,876,691 | · | 132,376,226 | 132,344,504 | 131,272,044 | · | 130,698,907 | 130,659,672 | 129,688,917 | · | 129,141,673 | |
| Shares (Diluted) | 136,505,102 | 134,417,158 | · | 135,187,592 | 134,882,981 | 132,876,691 | · | 132,376,226 | 132,344,504 | 131,272,044 | · | 130,698,907 | 130,659,672 | 129,688,917 | · | 129,141,673 | |
| EBITDA | $389M | $281M | · | $243M | $512M | $284M | · | $-205M | $238M | $231M | · | $173M | $246M | $210M | · | $204M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $149M | $712M | $260M | $123M | $456M | $431M | $37M | $33M | $39M | $48M | · | $91M | $118M | $144M | · | $300M | |
| Receivables | $2.14B | $2.14B | $2.08B | $2.16B | $2.26B | $2.33B | $2.29B | $2.04B | $2.19B | $2.19B | · | $2.16B | $2.04B | $2.04B | · | $1.97B | |
| Other Current Assets | $308M | $421M | $381M | $325M | $351M | $61M | $358M | $402M | $292M | $307M | · | $325M | $339M | $227M | · | $301M | |
| Current Assets | $3.08B | $3.77B | $3.23B | $3.20B | $3.66B | $3.41B | $3.30B | $3.11B | $3.20B | $3.17B | · | $3.25B | $3.19B | $3.11B | · | $3.27B | |
| PP&E (Net) | $4.18B | $4.20B | $4.50B | $4.62B | $4.66B | $4.74B | $4.78B | $4.96B | $5.22B | $5.22B | · | $5.16B | $5.25B | $5.25B | · | $5.45B | |
| PP&E (Gross) | $8.04B | $8.09B | $8.91B | $9.06B | $9.02B | $9.20B | $9.16B | $9.09B | $9.59B | $9.61B | · | $9.37B | $9.53B | $9.56B | · | $9.73B | |
| Accum. Depreciation | $3.86B | $3.89B | $4.41B | $4.44B | $4.37B | $4.46B | $4.38B | $4.13B | $4.37B | $4.39B | · | $4.21B | $4.28B | $4.30B | · | $4.28B | |
| Goodwill | $3.23B | $3.13B | $3.32B | $3.54B | $3.60B | $3.79B | $3.79B | $3.94B | $3.97B | $3.96B | $3.96B | $3.94B | $4.05B | $4.05B | $4.17B | $4.20B | |
| Intangibles | · | · | $7M | · | · | · | $15M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.65B | $2.05B | $2.10B | $1.81B | $1.71B | $1.94B | $2.17B | $1.86B | $1.99B | $2.04B | · | $2.27B | $2.10B | $2.15B | · | $1.94B | |
| Total Assets | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Accounts Payable | $713M | $790M | $842M | $894M | $970M | $974M | $913M | $842M | $896M | $941M | · | $837M | $736M | $712M | · | $820M | |
| Current Liabilities | $2.02B | $2.57B | $2.21B | $2.18B | $2.29B | $2.37B | $2.35B | $2.13B | $2.17B | $2.14B | · | $2.15B | $2.08B | $2.13B | · | $2.38B | |
| Capital Leases | $527M | $504M | $537M | $527M | $514M | $535M | $535M | $528M | $542M | $546M | · | $560M | $580M | $588M | · | $563M | |
| Deferred Tax | $25M | $25M | $25M | $30M | $240M | $205M | $231M | $239M | $351M | $354M | · | $344M | $362M | $351M | · | $477M | |
| Other Non-current Liabilities | $901M | $922M | $891M | $866M | $850M | $806M | $828M | $815M | $721M | $726M | · | $694M | $722M | $647M | · | $726M | |
| Total Liabilities | $13.02B | $14.14B | $14.04B | $14.19B | $14.74B | $15.22B | $15.37B | $15.18B | $15.29B | $15.29B | · | $15.57B | $15.47B | $15.41B | · | $16.09B | |
| Long-term Debt | · | · | $10.40B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $9.55B | $10.13B | · | $10.59B | $10.84B | $11.30B | · | $11.47B | $11.50B | $11.53B | · | $11.82B | $11.73B | $11.70B | · | $11.94B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Retained Earnings | $-3.56B | $-3.63B | $-3.57B | $-3.68B | $-3.81B | $-4.09B | $-4.08B | $-4.01B | $-3.62B | $-3.60B | · | $-3.61B | $-3.52B | $-3.48B | · | $-3.85B | |
| AOCI | $-11M | $-10M | $-9M | $-5M | $-5M | $-7M | $-10M | $-8M | $-13M | $-16M | · | $-23M | $-19M | $-18M | $-21M | $-33M | |
| Stockholders' Equity | $-1.39B | $-1.45B | $-1.39B | $-1.50B | $-1.63B | $-1.92B | $-1.91B | $-1.82B | $-1.44B | $-1.43B | · | $-1.46B | $-1.49B | $-1.45B | · | $-1.79B | |
| Liabilities + Equity | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Shares Outstanding | 141,010,284 | 140,916,712 | 138,626,917 | 140,119,616 | 140,119,616 | 140,302,924 | 138,919,641 | 138,936,058 | 138,960,194 | 138,966,388 | · | 136,772,094 | 136,802,806 | 136,749,427 | · | 134,698,067 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $108M | $114M | $108M | $108M | $105M | $105M | $129M | $117M | $125M | $115M | $121M | $128M | $124M | $132M | $136M | $137M | |
| Stock-based Comp | $2M | $3M | $5M | $-1M | $3M | $4M | $5M | $4M | $2M | $6M | $6M | $6M | $4M | $6M | $6M | $6M | |
| Operating Cash Flow | $88M | $-297M | $266M | $69M | $88M | $120M | $216M | $67M | $101M | $96M | $90M | $29M | $86M | $5M | $9M | $137M | |
| CapEx | $76M | $76M | $94M | $65M | $91M | $85M | $109M | $70M | $88M | $93M | $110M | $130M | $105M | $122M | $131M | $93M | |
| Investing Cash Flow | $-23M | $1.02B | $142M | $-81M | $342M | $444M | $-143M | $75M | $-108M | $-99M | $180M | $-101M | $-86M | $-19M | $-52M | $30M | |
| Net Debt Issued | · | $-351M | · | · | · | $-1.09B | · | · | · | $-885M | · | · | · | $-757M | · | · | |
| Financing Cash Flow | $-628M | $-274M | $-271M | $-321M | $-405M | $-170M | $-69M | $-148M | $-2M | $13M | $-323M | $45M | $-26M | $40M | $-139M | $-213M | |
| Net Change in Cash | $-563M | $452M | $137M | $-333M | $25M | $394M | $4M | $-6M | $-9M | $10M | $-53M | · | · | $26M | $-182M | $-46M | |
| Taxes Paid | $61M | $0 | $441M | $-91M | $181M | $80M | $303M | $-48M | $-84M | $0 | $152M | $-24M | $-37M | · | $0 | $0 | |
| Free Cash Flow | · | $-373M | · | · | · | $35M | · | · | · | $3M | · | · | · | $-117M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| Net Margin | 2.5% | -2.0% | · | 4.2% | 9.0% | -0.41% | · | -12.7% | -0.41% | -1.3% | · | -2.9% | -1.2% | -1.6% | · | -1.4% | |
| Pretax Margin | 6.4% | 2.2% | · | -0.06% | 14.0% | 2.1% | · | -13.6% | 1.6% | 0.70% | · | -1.1% | 1.3% | 0.19% | · | 2.3% | |
| EBITDA Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| ROA | 0.54% | -0.43% | · | 0.96% | 2.0% | -0.09% | · | -2.7% | -0.09% | -0.28% | · | -0.62% | -0.26% | -0.34% | · | -0.27% | |
| ROE | -4.6% | 3.4% | · | -7.8% | -18.4% | 0.78% | · | 23.8% | 0.89% | 2.9% | · | 5.6% | 2.4% | 3.6% | · | 2.5% | |
| ROIC | 2.8% | -1.3% | · | -228.6% | 4.1% | 1.1% | · | -1.8% | 1.2% | -0.62% | · | 2.6% | 0.12% | -6.8% | · | 0.00% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | · | 1.5 | 1.6 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.2 | 1.2 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 | |
| LT Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.5 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-9.86 | $-10.32 | · | $-10.72 | $-11.64 | $-13.71 | · | $-13.12 | $-10.37 | $-10.28 | · | $-10.70 | $-10.88 | $-10.57 | · | $-13.26 | |
| Revenue / Share | $20.70 | $22.06 | · | $22.83 | $23.23 | $23.77 | · | $23.34 | $23.73 | $23.92 | · | $23.61 | $23.84 | $23.96 | · | $23.42 | |
| Cash Flow / Share | · | $-2.21 | · | · | · | $0.90 | · | · | · | $0.73 | · | · | · | $0.04 | · | · | |
| Cash / Share | $1.06 | $5.05 | · | $0.88 | $3.25 | $3.07 | · | $0.24 | $0.28 | $0.35 | · | $0.67 | $0.86 | $1.05 | · | $2.23 | |
| EPS (TTM) | $1.86 | $3.44 | · | $2.42 | $-1.49 | $-3.68 | · | $-3.01 | $-0.75 | $-0.94 | · | $1.82 | $2.19 | $-0.04 | · | $-1.47 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.98B | $12.29B | · | $12.64B | $12.65B | $12.65B | · | $12.55B | $12.55B | $12.52B | · | $12.45B | $12.39B | $12.21B | · | $12.30B | |
| Net Income TTM | $252M | $464M | · | $328M | $-193M | $-488M | · | $-398M | $-98M | $-123M | · | $235M | $284M | $-4M | · | $-192M | |
| Market Cap | $471M | $414M | · | $450M | $476M | $379M | · | $843M | $467M | $486M | · | $397M | $602M | $670M | · | $290M | |
| Enterprise Value | $9.87B | $9.83B | · | $10.92B | $10.86B | $11.25B | · | $12.28B | $11.93B | $11.97B | · | $12.13B | $12.21B | $12.22B | · | $11.93B | |
| P/E | 1.8 | 0.9 | · | 1.3 | -2.3 | -0.7 | · | -2.0 | -4.5 | -3.7 | · | 1.6 | 2.0 | -122.5 | · | -1.5 | |
| P/S | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| P/B | -0.3 | -0.3 | · | -0.3 | -0.3 | -0.2 | · | -0.5 | -0.3 | -0.3 | · | -0.3 | -0.4 | -0.5 | · | -0.2 | |
| P / Cash Flow | · | -1.4 | · | · | · | 3.2 | · | · | · | 5.1 | · | · | · | 134.0 | · | · | |
| EV / Revenue | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Earnings Yield | 55.7% | 117.0% | · | 75.4% | -43.8% | -136.3% | · | -49.6% | -22.3% | -26.9% | · | 62.8% | 49.8% | -0.82% | · | -68.4% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B |
| Faaliyet Kâr Marjı % | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% |
| Net Gelir | $509M | $-516M | $-133M | $46M | $230M |
| Seyreltilmiş Hisse Başı Kâr | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 |
| Cari Oran | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 |
| Cari Oran | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $208M | $120M | $-257M | $-115M | $-600M |
Kurumsal Sahipler (13F) 197 dosya · $415.1M toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 31 (+9 önceki Ç'ye göre) | 24 (+4 önceki Ç'ye göre) | 69 (+6 önceki Ç'ye göre) | 54 (-9 önceki Ç'ye göre) | +7.0M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| CastleKnight Management LP | $44.704.517 | 13.384.586 | 10,77% | Hisse senetleri |
| Apollo Management Holdings, L.P. | $39.610.817 | 11.859.526 | 9,54% | Hisse senetleri |
| BlackRock, Inc. | $36.507.995 | 10.930.538 | 8,79% | Hisse senetleri |
| VANGUARD GROUP INC | $28.605.579 | 9.168.455 | 6,89% | Hisse senetleri |
| Eversept Partners, LP | $26.267.680 | 7.864.575 | 6,33% | Hisse senetleri |
| NOMURA HOLDINGS INC | $22.388.384 | 6.703.109 | 5,39% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $17.668.370 | 5.289.931 | 4,26% | Hisse senetleri |
| WHITEBOX ADVISORS LLC | $12.467.362 | 3.732.743 | 3,00% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $10.582.352 | 3.167.702 | 2,55% | Hisse senetleri |
| STATE STREET CORP | $10.226.622 | 3.061.863 | 2,46% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10.082.117 | 3.018.598 | 2,43% | Hisse senetleri |
| Saba Capital Management, L.P. | $9.626.444 | 2.882.169 | 2,32% | Hisse senetleri |
| Owl Creek Asset Management, L.P. | $8.452.277 | 2.530.622 | 2,04% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8.176.380 | 2.448.018 | 1,97% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $7.854.253 | 2.351.460 | 1,89% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $7.829.388 | 2.344.128 | 1,89% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $7.651.362 | 2.290.827 | 1,84% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $7.365.822 | 2.205.336 | 1,77% | Hisse senetleri |
| Diameter Capital Partners LP | $6.138.793 | 1.837.962 | 1,48% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $5.903.847 | 1.767.619 | 1,42% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $5.868.073 | 1.756.908 | 1,41% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $5.816.476 | 1.864.255 | 1,40% | Hisse senetleri |
| CARRONADE CAPITAL MANAGEMENT, LP | $5.230.000 | 1.565.847 | 1,26% | Hisse senetleri |
| Allianz Asset Management GmbH | $5.167.919 | 1.547.281 | 1,24% | Hisse senetleri |
| MORGAN STANLEY | $4.800.489 | 1.437.272 | 1,16% | Hisse senetleri |
| NORTHERN TRUST CORP | $4.681.414 | 1.401.621 | 1,13% | Hisse senetleri |
| Silver Rock Financial LP | $3.674.000 | 1.100.000 | 0,89% | Hisse senetleri |
| CITADEL ADVISORS LLC | $3.475.360 | 1.040.527 | 0,84% | Hisse senetleri |
| Assenagon Asset Management S.A. | $2.788.275 | 834.813 | 0,67% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $2.642.231 | 791.087 | 0,64% | Hisse senetleri |
| Jefferies Financial Group Inc. | $2.481.286 | 742.900 | 0,60% | Hisse senetleri |
| Alta Fundamental Advisers LLC | $2.161.411 | 647.129 | 0,52% | Hisse senetleri |
| Bank of New York Mellon Corp | $2.122.084 | 635.354 | 0,51% | Hisse senetleri |
| MARSHALL WACE, LLP | $1.906.575 | 570.831 | 0,46% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $1.701.580 | 509.455 | 0,41% | Hisse senetleri |
| ExodusPoint Capital Management, LP | $1.664.603 | 498.384 | 0,40% | Hisse senetleri |
| READYSTATE ASSET MANAGEMENT LP | $1.657.729 | 496.326 | 0,40% | Hisse senetleri |
| WOLVERINE ASSET MANAGEMENT LLC | $1.339.674 | 401.100 | 0,32% | Alım opsiyonu |
| Helix Partners Management LP | $1.336.000 | 400.000 | 0,32% | Hisse senetleri |
| Susquehanna Portfolio Strategies, LLC | $1.280.940 | 383.515 | 0,31% | Hisse senetleri |
| Voleon Capital Management LP | $1.247.032 | 373.363 | 0,30% | Hisse senetleri |
| Invesco Ltd. | $1.076.599 | 322.335 | 0,26% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $999.388 | 299.218 | 0,24% | Hisse senetleri |
| Pathstone Holdings, LLC | $895.621 | 268.150 | 0,22% | Hisse senetleri |
| Prescott Group Capital Management, L.L.C. | $863.076 | 258.406 | 0,21% | Hisse senetleri |
| UBS Group AG | $851.089 | 254.817 | 0,21% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $835.000 | 250.000 | 0,20% | Satım opsiyonu |
| FEDERATED HERMES, INC. | $812.599 | 243.293 | 0,20% | Hisse senetleri |
| LPL Financial LLC | $737.239 | 220.730 | 0,18% | Hisse senetleri |
| IEQ CAPITAL, LLC | $657.963 | 196.995 | 0,16% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 başvurular | 11 Mart 2021 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 56 içeriden öğrenenler · 29 yöneticiler · 23 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Kevin J Hammons | CEO | 01 Mart 2026 A | 895.545 | 0 | 0 | $0 |
| Tim Hingtgen | CEO | 01 Mart 2025 A | 1.388.781 | 0 | 0 | $0 |
| Jason K Johnson | EVP & CFO | 01 Mart 2026 A | 268.439 | 0 | 0 | $0 |
| Thomas J Aaron | EVP and CFO | 07 Aralık 2019 F | 241.515 | 0 | 0 | $0 |
| Larry W Cash | President and CFO | 01 Mart 2017 A | 568.152 | 0 | 0 | $0 |
| Miguel S Benet | President and CMO | 01 Mart 2025 D | 47.635 | 0 | 0 | $0 |
| Austen D Mason | Regional President | 01 Mart 2025 A | 142.500 | 0 | 0 | $0 |
| Mark B Medley | Regional President | 01 Mart 2025 A | 128.637 | 0 | 0 | $0 |
| Chad A Campbell | Regional President | 01 Mart 2025 A | 136.815 | 0 | 0 | $0 |
| Charles J Cova | Regional President | 01 Mart 2024 A | 58.701 | 0 | 0 | $0 |
| Lynn T Simon | President and CMO | 01 Mart 2024 A | 482.657 | 0 | 0 | $0 |
| Beryl Ramsey | Division President | 01 Mart 2019 A | 62.969 | 0 | 0 | $0 |
| Patton Paul Smith | Division President | 01 Mart 2019 F | 119.017 | 0 | 0 | $0 |
| Iii John W Mcclellan | Division President | 01 Mart 2017 A | 41.242 | 0 | 0 | $0 |
| Robert O Horrar | Division President | 01 Mart 2017 A | 68.649 | 0 | 0 | $0 |
| Martin Bonick | Division President | 01 Mart 2017 A | 100.458 | 0 | 0 | $0 |
| Michael T Portacci | Division President | 01 Mart 2017 A | 110.156 | 0 | 0 | $0 |
| Thomas Daniel Miller | Division President | 01 Mart 2016 A | 112.107 | 0 | 0 | $0 |
| David Lewis Miller | President and COO | 01 Mart 2016 A | 440.840 | 0 | 0 | $0 |
| William S Hussey | Division President | 28 Ekim 2015 M | 121.568 | 0 | 0 | $0 |
| Martin Dewayne Smith | Division President | 03 Haziran 2015 M | 94.111 | 0 | 0 | $0 |
| Gary D Newsome | Division President - Group Ops | 25 Ağustos 2008 M | 118.286 | 0 | 0 | $0 |
| David V. Rice | EVP-Clinical Operations & CMO | 01 Haziran 2026 A | 30.000 | 0 | 0 | $0 |
| Phillip A. Posey | SVP & CAO | 01 Mart 2026 A | 51.736 | 0 | 0 | $0 |
| Justin D Pitt | Pres,Chief Legal&Admin Officer | 01 Mart 2026 A | 287.750 | 0 | 0 | $0 |
| Kevin A Stockton | EVP, Operations & Development | 01 Mart 2026 A | 208.290 | 0 | 0 | $0 |
| Rachel A Seifert | Executive VP and Secretary | 01 Mart 2017 F | 243.065 | 0 | 0 | $0 |
| Mark T Buford | SVP/Chief Accounting Officer | 25 Şubat 2012 F | 78.379 | 0 | 0 | $0 |
| Martin G Schweinhart | Senior Vice President | 01 Mart 2006 A | 40.354 | 0 | 0 | $0 |
| William Norris Jennings | Yönetim kurulu üyesi | 25 Ağustos 2026 S | 38.468 | 0 | 1 | $-118.400 |
| Ranga K Krishnan | Yönetim kurulu üyesi | 30 Haziran 2026 M | 170.023 | 0 | 0 | $0 |
| Fawn D Lopez | Yönetim kurulu üyesi | 01 Mart 2026 A | · | 0 | 0 | $0 |
| Ronald L Burgess JR | Yönetim kurulu üyesi | 01 Mart 2026 A | · | 0 | 0 | $0 |
| Susan W Brooks | Yönetim kurulu üyesi | 01 Mart 2026 A | 108.695 | 0 | 0 | $0 |
| Hubert James Williams | Yönetim kurulu üyesi | 01 Mart 2026 A | 211.863 | 0 | 0 | $0 |
| Joseph Arthur Hastings | Yönetim kurulu üyesi | 01 Mart 2026 A | 0 | 0 | 0 | $0 |
| Elizabeth T Hirsch | Yönetim kurulu üyesi | 01 Mart 2026 A | 162.059 | 0 | 0 | $0 |
| James S. Ely III | Yönetim kurulu üyesi | 01 Mart 2026 A | 412.876 | 0 | 0 | $0 |
| John A Fry | Yönetim kurulu üyesi | 01 Mart 2026 A | 268.966 | 0 | 0 | $0 |
| John A Clerico | Yönetim kurulu üyesi | 01 Mart 2026 A | 368.763 | 0 | 0 | $0 |
| Michael Dinkins | Yönetim kurulu üyesi | 01 Mart 2026 A | 225.882 | 0 | 0 | $0 |
| Wayne T Smith | Yönetim kurulu üyesi | 01 Mart 2026 A | 5.217.579 | 0 | 0 | $0 |
| Julia B North | Yönetim kurulu üyesi | 01 Mart 2021 A | 162.056 | 0 | 0 | $0 |
| Mitchell H Watson JR | Yönetim kurulu üyesi | 16 Mayıs 2017 M | 22.594 | 0 | 0 | $0 |
| Harvey Klein MD | Yönetim kurulu üyesi | 15 Mart 2010 M | 10.383 | 0 | 0 | $0 |
| Dale F Frey | Yönetim kurulu üyesi | 31 Mart 2008 A | 20.000 | 0 | 0 | $0 |
| Thomas H Lister | Yönetim kurulu üyesi | 21 Eylül 2004 S | 0 | 0 | 0 | $0 |
| Thodore Forstmann | Yönetim kurulu üyesi | 21 Eylül 2004 S | 0 | 0 | 0 | $0 |
| Sandra Horbach | Yönetim kurulu üyesi | 21 Eylül 2004 S | 0 | 0 | 0 | $0 |
| Robert J Dole | Yönetim kurulu üyesi | 06 Mayıs 2004 S | 0 | 0 | 0 | $0 |
| FLC XXIX PARTNERSHIP LP | 10% sahip | 21 Eylül 2004 S | 0 | 0 | 0 | $0 |
| FLC XXX PARTNERSHIP LP | 10% sahip | 21 Eylül 2004 S | 0 | 0 | 0 | $0 |
| Winston Hutchins | 10% sahip | 21 Eylül 2004 S | 0 | 0 | 0 | $0 |
| FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP | 10% sahip | 21 Eylül 2004 S | 0 | 0 | 0 | $0 |
| FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P | 10% sahip | 21 Eylül 2004 S | 0 | 0 | 0 | $0 |
| Benjamin C Fordham | · | 01 Mart 2021 A | 254.608 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 25 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BSJR · Invesco Exchange-Traded Self-Indexe… | 2,68% | 23.297.000 | 01 Ekim 2026 | Günlük |
| EBIT · Harbor ETF Trust | 0,45% | 19.210 NS | 31 Temmuz 2026 | N-PORT |
| IWC · iShares Trust | 0,09% | 443.690 SH | 11 Eylül 2026 | Günlük |
| IHF · iShares Trust | 0,05% | 223.947 SH | 11 Eylül 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 113.109 SH | 19 Ağustos 2026 | Günlük |
| NEAR · iShares U.S. ETF Trust | 0,03% | 1.340.000 SH | 11 Eylül 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 226.491 SH | 01 Ekim 2026 | Günlük |
| IWM · iShares Trust | 0,01% | 3.425.206 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,01% | 62.038 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 746.733 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,01% | 349.881 SH | 19 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,01% | 289.348 NS | 31 Temmuz 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 202.789 NS | 31 Temmuz 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 33.838 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 203.848 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 42.177 SH | 03 Eylül 2026 | Günlük |
| DCOR · Dimensional ETF Trust | 0,00% | 6.184 NS | 31 Temmuz 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 31.135 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.347.195 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.813.888 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.817 SH | 19 Ağustos 2026 | Günlük |
| DFSU · Dimensional ETF Trust | 0,00% | 24 NS | 31 Temmuz 2026 | N-PORT |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | 15 Temmuz 2026 | Günlük |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 Temmuz 2026 | Günlük |
| IWN · iShares Trust | · | 1.223.127 SH | 11 Eylül 2026 | Günlük |
CYH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
12 Aylık Fiyat Hedefi
8 analist · 2026-10-01Ortalama hedef $3.16 +16,0%
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CYH | $433M | 0.8 | -1.2% | 4.1% | -30.8% | · |
| SGRY | $2.00B | -25.3 | 6.2% | -2.4% | -4.5% | · |
| NUTX | $1.17B | 15.7 | 82.4% | 8.1% | 30.6% | 50.8% |
| ARDT | $1.26B | 9.2 | 6.0% | 2.1% | 11.2% | · |
| USPH | · | 55.0 | 16.3% | 5.1% | 8.2% | 19.2% |
| STLN | · | · | · | · | · | · |
| JYNT | $123M | 45.9 | 5.2% | 5.3% | 16.3% | · |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.